Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer
Position
Chief Financial Officer
Company
Intra-Cellular Therapies
Description
Intra-Cellular Therapies, Inc. announced that Sanjeev Narula will join the Company on August 12, 2024 as Executive Vice President, Chief Financial Officer, reporting to Dr. Sharon Mates, ITCI’s Chairman and Chief Executive Officer.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer (August 13, 2024)
- Pfizer Appoints Berta Rodriguez-Hervas as Chief AI and Analytics Officer (August 13, 2024)
- Oculis Appoints Dr. Sharon Klier as Chief Development Officer (August 15, 2024)
- Fulcrum Therapeutics Appoints Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer (August 19, 2024)
- Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer (July 16, 2024)
- Belite Bio, Inc Appoints Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer (September 1, 2024)
Who to call at Intra-Cellular Therapies, and when
A new leader at Intra-Cellular Therapies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Intra-Cellular Therapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Intra-Cellular Therapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Intra-Cellular Therapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Intra-Cellular Therapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Intra-Cellular Therapies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.